Equitable implementation of COVID‐19 vaccine delivery is a national and global priority, with a strong focus on reducing existing disparities and not creating new disparities. But while a framework has been recognized for equitable allocation of COVID‐19 vaccine that acknowledges the rights and interests of sexual and gender minorities (SGM), it fails to identify strategies or data to achieve that goal.
The principal investigators of the Moderna and Johnson & Johnson COVID-19 vaccine clinical trials at Rutgers discuss how the university became a site and their challenges and successes. The Rutgers J&J trial site was the second-largest clinical trial for the company.
The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.
New research from Washington University School of Medicine in St. Louis has found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic, potentially undermining the effectiveness of vaccines and antibody-based drugs now being used to prevent or treat COVID-19.
St. Jude is dedicating staff and resources to focus on the prevention of human papillomavirus (HPV)-related cancers around the world through HPV vaccine awareness programming.
Fact-checking a false claim about COVID-19 vaccines
Research out on the pre-publication website medRxiv shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.
SEATTLE — March 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.March is Women’s History month. We’d like to honor Dottie Thomas, known as the “mother of bone marrow transplantation.” She spent years working as a research partner alongside her husband, Nobel Prize-winning Dr.
Lymph nodes in the armpit area can become swollen after a COVID-19 vaccination, and this is a normal reaction that typically goes away with time.
The production of autogenous vaccines to fight individual strains of the virus that causes porcine reproductive and respiratory syndrome depends on the ability of scientists to isolate the virus, but sometimes that’s a tricky process. A new study from an Iowa State University researcher shows that a new cell line may offer a better alternative to the cell line most commonly used to isolate the PRRS virus. But the vast majority of vaccine producers use the established cell line, and it remains to be seen how readily they might adopt the use of a new one.
A novel computer algorithm that could create a broadly reactive influenza vaccine for swine flu also offers a path toward a pan-influenza vaccine and possibly a pan-coronavirus vaccine as well, according to a new paper published in Nature Communications.
A new article published online in the Journal of the American College of Radiology (JACR®) explains how patients recently vaccinated for COVID-19 can experience false-positive imaging exams and outlines steps providers can take to reduce unwarranted follow-up care for these findings.
Duke researchers describe a new vaccination strategy that they think could re-program the body to fight off the bacteria that cause urinary tract infections.
After a year of racial unrest due to the killing of unarmed Black men and women and the upending of our regular lives due to the COVID-19 pandemic, many have forged a new outlook on life. Two Black Rutgers female faculty share their reflections on the past year and their hopes for the future.
Innova Medical Group, Inc., the world's largest manufacturer of rapid antigen test kits and leader in COVID-19 testing solutions globally, announced today the appointment of Sean Rogers as Chairman of Innova Medical Group, and Todd Malan, M.D., as Innova's Chief Medical Officer.
While the Johnson & Johnson single-dose COVID-19 vaccine that has now received emergency use authorization by the U.S. Food and Drug Administration has a lower efficacy rate compared to other previously approved vaccines, an expert with The University of Texas Health Science Center at Houston (UTHealth) explains why it is still a significant step toward ending the COVID-19 pandemic.
Several proposals have emerged on how to distribute the COVID-19 vaccine, but they fall short in ensuring that the vaccine is distributed fairly. A team including Binghamton University professor Nicole Hassoun suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible.
The American Association of Nurse Anesthetists (AANA) is part of a national campaign to provide fact-based answers to questions about the COVID-19 vaccine.
The March edition of SLAS Discovery features the cover article, “Therapeutic and Vaccine Options for COVID-19: Status After 6 Months of the Disease Outbreak” by Christian Ogaugwu (Federal University Oye-Ekiti, Ekiti State, Nigeria ), Dawid Maciorowski, Subba Rao Durvasula, Ph.D., Ravi Durvasula, M.D., and Adinarayana Kunamneni, Ph.D. (Loyola University Medical Center, Maywood, IL, USA).
Pregnant women are at increased risk of severe COVID-19. Also, many women of childbearing age have increased COVID-19 exposure risks, including healthcare providers and other workers providing essential services.
Washington, DC (February 25, 2021) —The American Society of Nephrology (ASN) is spearheading efforts to secure direct federal allocation of COVID-19 vaccines to dialysis patients and frontline dialysis workers. This allocation would improve access for a vulnerable patient population, more than half of whom are Black, Hispanic, Asian, Native American, and Native Hawaiian or other Pacific Islanders (NHPIs).
A study from Michigan State University that found in spite of Black Americans’ attitudes toward proper precautions, they are disproportionately impacted by the pandemic and White people are less likely to fall ill.
ROCKVILLE, MD – The virus that causes COVID-19 belongs to the family of coronaviruses, “corona” referring to the spikes on the viral surface.
The panel of experts will discuss recent trials that have demonstrated efficacy for the vaccine, despite an early release in August 2020 which was met with skepticism by the international community.
The percentage of people globally who say they will get a COVID-19 vaccine has fallen in recent weeks, even as tens of millions of doses have been administered around the world, new survey data suggest.
More U.S. adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before, according to findings from a December 2020 national survey.
Reports on variants of the coronavirus that causes COVID-19 have swept the news over the past few months, but what exactly is a virus variant?
The George Washington University is a site for a phase 2 clinical trial for Sanofi's adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Keck Medicine of USC experts discuss community vaccine initiatives and COVID-19 variants
In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal antibodies, which hindered the growth of tuberculosis germs in laboratory mice.
روتشستر، ولاية مينيسوتا: إن المرضى المصابين بفيروس الكورونا المستجد (كوفيد-19) عرضة لمجموعة من المضاعفات العصبية التي تشتمل على التهاب الدماغ.
Los pacientes con COVID-19 corren riesgo de presentar complicaciones neurológicas, incluida una encefalitis o inflamación del cerebro.
A team of researchers at Beth Israel Deaconess Medical Center (BIDMC) has developed a mathematical means of assessing tests’ false-negative rate.
Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of the brain. "Encephalitis cases have been reported in patients with COVID-19, although on the whole it appears to be a relatively rare complication," says Michel Toledano, M.D., a Mayo Clinic neurologist. In the case of encephalitis caused by communicable diseases for which there is a vaccine available, getting vaccinated is the best way of preventing the disease.
The approval of COVID-19 vaccines has brought with it hope, excitement, as well as concerns. AARDA is committed to ensuring you have the information you need to make the right decisions for your health. A panel of medical experts will discuss frequently asked questions regarding COVID-19 vaccines, as well as address audience questions during our upcoming Autoimmune Newscast, “Should I Get the COVID-19 Vaccine?” on 2/26 at 2pm ET
Press conference will discuss COVID-19 vaccine research, development, rollout in conjunction with the COVID-19 Vaccine Development, Strategy and Implementation Virtual Global Health Symposium, organized by Columbia University, running from 22-26 February
International experts are joining forces to combat vaccine hesitancy by tackling its root cause – misinformation – and arming key influencers with the facts.
Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease.
The Johns Hopkins School of Nursing (JHSON) has launched a free online course to help individuals, health departments, and other community organizations be trained to administer COVID-19 vaccination. The course covers vaccine safety, hesitancy, preparation, administration, and side effects.
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
A new Johns Hopkins data tool helps people with disabilities determine when they qualify for the COVID-19 vaccine and compares how different states prioritize the disability community in the vaccine rollout. Created by researchers, students and advocates who themselves are disabled and have personally experienced how inequitable and inaccessible the pandemic response has been, the COVID-19 Vaccine Prioritization Dashboard launched to not only help the disability community get vaccinated, but also to arm policymakers with data to improve the system.
A new analysis from the Geiger Gibson/RCHN Community Health Foundation Research Collaborative provides current information on the number of community health center staff members and patients who have received COVID-19 vaccines, using data from the latest published Health Resources and Services Administration’s Health Center COVID-19 Survey. The Geiger Gibson/RCHN Community Health Foundation Research Collaborative is based at the George Washington University Milken Institute School of Public Health (GW Milken Institute SPH).
For some people, anxiety over what may happen after they get the COVID-19 vaccine seems to almost outweigh the relief of getting protected. Here are some common questions and answers that should ease concerns.
130 cancer centers and other cancer organizations sent a letter to President Joseph R. Biden, key members of his administration, and leading state public health officials to strongly encourage prioritizing patients with cancer and survivors of cancer when administering lifesaving COVID-19 vaccines.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right